How much funding has Asymchem raised?

Asymchem has raised $2.3B in total funding, most recently a Private Equity round.

Who are Asymchem's investors?

Asymchem's investors include Goldman Sachs, Tianyi Medical Private Equity.

Where is Asymchem headquartered?

Asymchem is headquartered in Tianjin, China.

What industry is Asymchem in?

Asymchem operates in Healthcare, Biotech, CDMO, Life Sciences, Drug Discovery.

How many employees does Asymchem have?

Asymchem has 5001-10000 employees.

Asymchem

IPO

Innovative CDMO Solutions in an Ever-Changing World

Public · Tianjin, China · Founded 1999 · $2.3B raised

CDMO

Headquarters: Tianjin
Employees: 5001–10000
Founded: 1999
Business Model: B2B
Website: asymchem.com

Total Funding: $2.3B
Last Round: $2.3B Private EquityFeb 2020
Rounds: 2
Type: Public

About

Asymchem is a global contract development and manufacturing organization (CDMO) founded in 1999, providing integrated R&D and one-stop production services to the world's top pharmaceutical companies. The company offers comprehensive CMC services covering the full lifecycle of drug development — from early clinical stage through commercial manufacturing — including advanced intermediates, APIs, formulations, and clinical research services. Asymchem is a recognized leader in green chemistry and novel manufacturing technologies including continuous flow chemistry, biocatalysis, fermentation, and electrochemistry, enabling cost-effective and environmentally responsible pharmaceutical synthesis.

Summary

Asymchem is a Healthcare company based in Tianjin, China, founded in 1999. It has raised $2.3B in total across 2 rounds, most recently a $2.3B Private Equity round in Feb 2020. Investors include Goldman Sachs and Tianyi Medical Private Equity.

LinkedIn X (Twitter)